Fred Hutchinson Transplant Program at SCCA
If your condition requires a bone marrow transplant, you should know that the Fred Hutchinson Transplant Program at SCCA ranked among top centers in survival rates in a multi-year study by the National Marrow Donor Program that measured one-year survival rates of patients at 122 transplant centers in the United States. Even patients who have not found a matching donor may find treatments here via what are called alternative donor methods. The Hutchinson Center pioneered the use of bone marrow transplants as a treatment for blood diseases more than 40 years ago. Since then thousands of patients with leukemia have come here from around the world to receive bone marrow transplants. Bone marrow transplants have transformed leukemia and related cancers, once thought incurable, into highly treatable diseases.
Most Experienced Transplant Center in the World
Doctors at the Fred Hutchinson Bone Marrow Transplant Program at Seattle Cancer Care Alliance have performed more than 14,000 bone marrow transplants—more than any institution in the world. These include alternatives for patients who do not find a donor match. Two leading therapies are cord blood transplant and half-match or halploidentical transplant. Read more about Alternative Donor Program here. The diseases we treat most often are lymphoma, multiple myeloma, and acute myelogenous leukemia, but our doctors are also advancing the use of bone marrow transplants for additional cancers, bone marrow deficiencies, inborn errors of metabolism, and immune disorders. Our program consistently ranks among the country’s top transplant centers in one-year survival rates.
Access to the Latest Transplant Research and Techniques
Clinical use of bone marrow and stem cell transplantation was first developed at the Hutchinson Center, and one of Hutchinson Center’s founders, Dr. E. Donnall Thomas, won the Nobel Prize in 1990 for this groundbreaking work. Since then, Hutchinson Center has pioneered the use of less-toxic mini-transplants, cord blood for stem cell transplants, and transplants to treat many kinds of cancer, bone marrow deficiencies, and immune disorders.